Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139.
Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139.
复制标题
对 Goldfine 等人的评论的回应
DOI：
10.2337/dc14-0222
复制
发表时间：
2014
期刊：
影响因子：
16.2
通讯作者：
TINSAL-FMD(TargetingInflammationUsingSalsalateinType2Diabetes–Flow-MediatedDilation)AncillaryStudyTeam
中科院分区：
文献类型：
--
作者：
Goldfine,AllisonB;Jablonski,KathleenA;Shoelson,StevenE;Creager,MarkA;TINSAL-FMD(TargetingInflammationUsingSalsalateinType2Diabetes–Flow-MediatedDilation)AncillaryStudyTeam
